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Abstract
Background: Cross-sectional studies have reported associations between allergies and major
depression but in the absence of longitudinal data, the implications of this association remain
unclear. Our goal was to examine this association from a longitudinal perspective.
Methods: The data source was the Canadian National Population Health Survey (NPHS). This
study included a short form version of the Composite International Diagnostic Interview (CIDI-SF)
to assess major depression and also included self report items for professionally diagnosed allergies
of two types: non-food allergies and food allergies. A longitudinal cohort was followed between
1994 and 2002. Proportional hazards models for grouped time data were used to estimate
unadjusted and adjusted hazard ratios.
Results: A slightly increased incidence of non-food allergies in respondents with major depression
was observed: adjusted hazard ratio 1.2 (95% 1.0 – 1.5, p = 0.046). Some evidence for an increased
incidence of major depression in association with non-food allergies was found in unadjusted
analyses, but the association did not persist after multivariate adjustment. Food allergies were not
associated with major depression incidence, nor was major depression associated with an
increased incidence of food allergies.
Conclusion: Findings from the present study support the idea that major depression is associated
with an increased risk of developing non-food allergies. An effect in the opposite direction could
not be confirmed. The observed effect may be due to shared genetic factors, epigenetic factors, or
immunological changes that occur during depression.
Background
An association between allergies and depressive disorders
has been suspected for many years. However, early studies
typically used clinical subjects [1] and/or non-standard
psychiatric measurement strategies [2]. Only a few epide-
miological studies have examined associations between
allergies and psychiatric symptoms in non-clinical popu-
lations. A recent cross-sectional study in Canada con-
firmed that an association exists between self-reported
allergies and depressive disorders in the general popula-
tion [3].
Wamboldt et al. [4] studied depressive symptoms in peo-
ple with allergies in a mail survey of a Finnish twin sam-
ple. The survey included the Beck Depression Inventory
[5] and a series of questions about atopic disorders. Sub-
jects reporting three or more atopic disorders were found
to have an elevated probability of exceeding a threshold
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score on the Beck Depression Inventory. Co-twins of sub-
jects reporting three or more atopic disorders also more
frequently had elevated depression scores; however, there
was no difference between dizygotic and monozygotic
twins. Nevertheless, modelling results were interpreted as
providing support for shared familial vulnerability. The
idea of shared genetic vulnerability received additional
support from a study using data on parent-child dyads in
the National Health Interview Survey in the US. In this
study, an association between parental depressive disor-
ders and atopy in the children was found in biological,
but not adoptive, dyads [6].
Timonen et al. [7] studied a 1966 Finnish birth cohort in
an investigation that included skin tests to three common
allergens as well as several questions about depression
and two depression rating scales. Compared to women
with negative skin tests, women with positive skin tests
were slightly more likely to report that they had been diag-
nosed with depression by a doctor (6.9% versus 4.3%),
but no difference was found in men. However, a subse-
quent report cast some doubt on whether the association
is unique to women. When depressive symptom ratings
were incorporated along with physician diagnoses in the
definition of depression, a significant association was also
observed in men with high symptom levels [8]. Another
report from the same study indicated that maternal atopy
(assessed indirectly using a questionnaire completed by
the proband) was a risk factor for depression in the
proband [9].
Another link between allergies and mood was suggested
by the observation, based on analysis of a suicide registry,
that there is a springtime preponderance of suicides in
people previously hospitalized for atopic disorders [10].
Finally, a case-control study investigating the prevalence
of cognitive dysfunction in people with allergic rhinitis
also reported elevated depression symptom ratings in the
allergic rhinitis cases [11].
Various potential explanations for the epidemiologic
association between depression and allergies have been
put forward. Some of these explanations imply shared eti-
ologic factors (especially shared genetic vulnerability),
others an effect of depression on allergy risk and others an
effect of allergies on depression risk. Any one, or all, of
these alternatives could explain the associations reported
in cross-sectional studies. However, they would have dif-
ferent implications for the longitudinal epidemiology.
The most prominent explanations have involved
cytokine-related mechanisms [10]. For example, shared
vulnerability factors may include genes involved in
immune regulation, consistent with the epidemiological
findings of Wambold [4] and Timonen [9]. On the other
hand, it has been asserted that the brain may interpret
immune activation much as if it were a stressor [12],
thereby triggering a stress response that may include
depression. Longitudinally, this would suggest that aller-
gies, which involve immune activation, may alter the risk
of major depression. Depressive disorders are associated
with elevated levels of pro-inflammatory cytokines such
as interleukin-1β, interleukin-6, tumour necrosis factor-α
and interferon-α [12]. These signalling molecules may
potentially contribute to the aetiology of some types of
allergies through their pro-inflammatory effects.
Responses to stressors and immune responses may share
underlying mechanisms [12], so it is also possible that
epigenetic mechanisms (e.g. alteration of chromatin
structure through effects on DNA methylation lead to a
lasting sensitization of stress response systems following
pre-natal or post-natal stress exposure [13]) could
increase the risk both of developing major depression and
developing allergies. In the case of food allergies, stressors
may also contribute to intestinal hypersensitivity by alter-
ing transepithelial permeability, see a brief review of pos-
sible mechanisms by Buret [14]. However, there is a
consensus that most self-reported food allergies in the
community are not attributable to Type I or Type IV
hypersensitivity [15], leading to the suspicion that there
may be false positive reports based on a misinterpretation
of somatic symptoms. These could also be related to
depressive disorders, since somatic symptoms can be a
manifestation of depression and anxiety. Finally, since
most chronic conditions are associated with depressive
disorders [16], it is possible that allergies may increase
depression risk through the stressful psychological effects
of the illness experience.
The extent of epidemiological data concerning the depres-
sion-allergy association is surprisingly limited. The Finn-
ish studies used self-reported lifetime depression, hospital
admission records or symptom rating scales to assess
depression. None of these measurement strategies are
generally considered adequate for psychiatric epidemio-
logical research. Generally, structured diagnostic inter-
views are the preferred approach. Depressive symptom
ratings tend to be neither sensitive nor specific for clini-
cally significant Axis I disorders such as depressive disor-
ders. The main deficit in the existing literature is the
paucity of longitudinal data. As noted above, it is possible
that allergies may increase depression risk or that depres-
sion may increase allergy risk, two distinct possibilities
that cannot be distinguished using cross-sectional data. In
order to address some of the weaknesses of prior studies
and to explore the etiological issues noted above, we
undertook an evaluation of the longitudinal epidemiol-
ogy of these variables using data collected in a large scale
population survey in Canada.BioPsychoSocial Medicine 2009, 3:3 http://www.bpsmedicine.com/content/3/1/3
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Methods
Study Design
The NPHS is based on a nationally representative commu-
nity sample assembled by Statistics Canada (Canada's
national statistical agency) in 1994. Detailed information
about the methods employed in this study may be found
on the Statistics Canada Web page http://www.Stat
Can.gc.ca. In brief, the National Population Health Survey
(NPHS) commenced in 1994 as a cross-sectional survey of
Canadian household residents, excluding some specific
groups (e.g. First Nations peoples living on reserves,
armed forces personnel) and some remote areas. The
NPHS sample has been re-interviewed every second year
in subsequent cycles. The initial interviews were con-
ducted face to face, but subsequent cycles have collected
data predominantly by telephone. An attrition analysis for
the NPHS was reported by Beaudet et al. [17]. Attrition
was found to be related to several variables, but not to
major depression. This is consistent with the literature of
prospective psychiatric epidemiological studies. Major
depression may increase loss to follow-up by mechanisms
such as "unable to locate," but tends to decrease the fre-
quency of refusal, such that the net effect on attrition is
weak [18,19]. Statistics Canada produces a longitudinal
data file that is made available to researchers through
Regional Data Centres, including one located on the Uni-
versity of Calgary campus where the current analysis was
conducted.
Participants
The longitudinal cohort included 17, 276 participants,
but the current analysis was restricted to n = 15,254
respondents who were over the age of 12 at the time of the
initial 1994 interview. The youngest of these respondents
would have been approximately 20 years old in 2002 at
the end of the follow-up interval examined in this study.
Measures
The NPHS interview includes a series of items concerned
with long-term medical conditions. Study participants
were read a list of chronic medical conditions and asked
whether they had been diagnosed with one of these con-
ditions by a health professional. The wording of the rele-
vant item was: Now I would like to ask about certain chronic
health conditions which you may have. We are interested in
long-term conditions that have lasted, or are expected to last, 6
months or more and that have been diagnosed by a health pro-
fessional. One of the subsequent items was, Do you have
food allergies? This was followed by, Do you have any other
allergies?
The interview also includes the Composite International
Diagnostic Interview short form (CIDI-SF) [20] for major
depression, which assesses past year major depressive epi-
sodes. In distinction to rating scales, the CIDI-SF is a con-
densed structured diagnostic instrument. It contains
branches, so that the questions asked depend on
responses to earlier items. The CIDI-SF uses a point-based
scoring algorithm that incorporates the number of symp-
tom-based criteria fulfilled and the necessity for at least
one of two key symptoms (depressed mood and loss of
interest or pleasure) in keeping with the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV) [21]. A
score of 5 on the CIDI-SF is also consistent with DSM-IV-
defined MD on the basis of face validity since the manual
requires fulfilment of five of nine specified symptoms,
including at least one of the two key symptoms. Further-
more, this cut-point maximized performance of the CIDI-
SFMD in a DSM-IIIR-based receiver operator curve analy-
sis carried out during the instrument's development,
where it was associated with a 90% positive predictive
value for major depression [20]. Due to a lack of "organic"
and hierarchical exclusion items, the CIDI-SFMD may be
vulnerable to false positive ratings. Consistent with this
idea, experience with the instrument suggests that it may
slightly overestimate prevalence [22]. However, any such
effects must be modest in magnitude, as the CIDI-SFMD
has produced credible estimates during applications in
Canada [23,24], the US [25,26] and elsewhere [27]. In the
NPHS and CCHS surveys the CIDI-SMFD has consistently
replicated the expected pattern and strength of association
with demographic and clinical variables [24,28-30]. Fur-
thermore, incidence estimates from the CIDI-SFMD
[29,30] are consistent with those of a systematic review of
high quality studies by Waraich et al. [31].
The NPHS also assessed smoking status and inquired into
a series of significant life stressors. These items were pre-
ceded by the statement: The next few questions ask about
some things that may have happened to you while you were a
child or a teenager, before you moved out of the house. Please
tell me if any of these things have happened. This was fol-
lowed by a list of seven stressful events: spending 2 weeks
or more in hospital, parents getting a divorce, prolonged
parental unemployment, something "scary" happening
that was thought about for years after, being sent away for
doing something wrong and parental alcohol or drug
abuse. Respondents answering affirmatively to any one of
these items were coded as positive for childhood stressors.
Because one of these stressors, prolonged hospitalization,
could be associated with allergies or depression, the anal-
ysis was repeated not-including this particular item. This
had no effect on the results and these analyses are not
reported.
Data Analysis
For the current analysis, one objective was to evaluate the
incidence of depressive episodes in people with allergies.
This was accomplished by excluding those respondents
having an episode of major depression at or in the yearBioPsychoSocial Medicine 2009, 3:3 http://www.bpsmedicine.com/content/3/1/3
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preceding the initial interview (n = 849). We also
excluded those who did not complete the CIDI-SF in 1994
(n = 1,230). We then assessed the frequency of subse-
quent episodes in n = 13,175 respondents without major
depression at the baseline interview. The incidence of
allergies was assessed by excluding the respondents who
reported allergies at the baseline interview (n = 2,641) or
had missing data on this variable (n = 23) and then com-
paring the frequency of new onset allergies in those with
and without depression. Similar analyses were conducted
to assess the incidence of allergies in those with a depres-
sive episode at any of the four available survey interviews
during follow-up, and to assess the incidence of food
allergies in those with major depression and the incidence
of depressive episodes in those with food allergies.
We initially calculated two-year incidence for the first
period of follow-up (1994 to 1996) and then stratified
these estimates by age and sex. Subsequently, propor-
tional hazards models were used to estimate the hazard
ratio for the entire 1994 to 2002 follow-up interval with
and without adjustment for potential confounding varia-
bles. Childhood stressors were considered potential con-
founders, based on data from New Zealand indicating
that these may be risk factors for asthma [32]. Smoking is
another variable that may act as a confounder because it is
a risk factor for depression and may protect against respi-
ratory allergies [33]. The proportional hazards model was
fit as a generalized linear model of the binomial family
with a complementary log-log link, as described by
Jenkins [34]. Age and sex were also included in these mod-
els.
The NPHS used a multistage, stratified cluster design to
select eligible households. To correct the potential bias
resulting from this complex survey design, Statistics Can-
ada recommends a bootstrap procedure using a set of rep-
licate weights that they supply. All results presented here
were produced with this approach and are therefore repre-
sentative of the targeted population. The standard error
associated with specific estimates, p-values and confi-
dence intervals (CIs) are adjusted for survey design effects
by the bootstrap weighting procedure. All analyses were
conducted using STATA [35]. The study received approval
from the University of Calgary Conjoint Ethics Board.
Results
Table 1 presents crude and stratified two-year incidence
for non-food allergies in the first NPHS cycle, between
1994 and 1996. The incidence was very high. The overall
incidence was 14.1% during this two year interval (95%
CI 13.1 – 15.0), and was slightly higher in those with
major depression at baseline, in women, in the younger
age categories, in non-smokers and those reporting child-
hood stressors, see Table 1. The pattern of higher inci-
dence in women and in younger age groups is consistent
with prior studies [33].
While non-food allergy incidence was very high in the first
cycle, it declined during each subsequent NPHS cycle,
with 2-year incidence being 8.5% (95% CI 7.6 – 9.3)
between 1996 and 1998, 6.9% (95% CI 6.0 – 7.7)
between 1998 and 2000 and 6.1% (95% CI 5.3 – 6.9)
between 2000 and 2002. The crude hazard ratio (HR) for
the effect of major depression at baseline (measured in
1994) on allergy incidence was 1.4 (95% CI 1.2 – 1.6, p <
0.001). No significant interaction terms were observed in
the proportional hazards models, but significant effects
were seen for sex (HR = 1.5, p < 0.001), smoking (HR =
0.8, p = 0.02) and childhood and adult stressors (HR =
1.2, p =< 0.001). After adjustment for all variables in Table
1, including age, the HR for the effect of major depression
at baseline on non-food allergy incidence was 1.2 (95%
1.0 – 1.5, p = 0.046), see Table 2.
As major depression is often conceptualized as a chronic,
recurrent condition [36], it is meaningful to examine the
incidence of allergies in respondents having an episode at
any time during the NPHS follow-up. The results were
similar to the previous analysis. Here, the adjusted HR for
the effect of depression on non-food allergy incidence was
1.3 (95% CI 1.1 to 1.6).
In the first NPHS cycle (1994 to 1996) the two-year inci-
dence for major depression was 3.5% (95% CI 3.1 – 4.1).
The 2-year incidence was 4.2% among those with non-
food allergies (95% CI 3.1 – 5.3) at baseline and 3.4% in
those without (95% CI 2.9 – 3.9). The 2-year incidence in
Table 1: Two-year non-food allergy incidence in the NPHS* 1994 





14.1 (13.1 – 15.0)
19.3 (14.9–23.7)
No major depression 13.8 (12.8–14.8)
Male 11.1 (9.9–12.3)
Female 16.9 (15.4–18.3)
Age 12–18** 16.7 (12.6–20.7)
Age 19–25 16.4 (13.5–19.3)
Age 26–45 14.5 (12.9–16.0)
Age 46–65 13.3 (11.7–14.9)
Age 66+ 10.3 (8.3–12.4)
Daily smoker 13.7 (11.8–15.6)
Never/former/occasional smoker 14.3 (13.3–15.4)
Reported childhood or adult stressors 15.9 (14.6–17.3)
No childhood or adult stressors reported 12.0 (10.8–13.2)
* National Population Health Survey
** age at the baseline interview in 1994BioPsychoSocial Medicine 2009, 3:3 http://www.bpsmedicine.com/content/3/1/3
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relation to demographic and clinical factors followed the
expected pattern, see Table 3.
Over the entire follow-up interval, an association between
non-food allergies at baseline and major depression inci-
dence was also observed, but only in unadjusted analyses.
The crude HR was 1.4 (95% CI 1.2 – 1.6, p < 0.001). After
adjustment for the variables listed in Table 3 the HR
diminished to 1.2 and was no longer statistically signifi-
cant (95% CI 0.9–1.4, p = 0.16). In these analyses, no
interactions were observed, but effects of sex, age and
childhood stress remained significant, see Table 4. Smok-
ing had the expected risk-elevating effect on major depres-
sion incidence in this model (HR = 1.8, 95% CI 1.5 – 2.1),
see Table 4.
The remaining analyses examined associations involving
food allergies rather than non-food allergies. The crude
HR for the effect of major depression at baseline on sub-
sequent food allergy risk was 1.4 (95% CI 1.1 – 1.8). After
adjustment for the factors listed in Table 1 the HR was
diminished to 1.2 (0.9 – 1.5, p = 0.33). Childhood stres-
sors were significantly associated with food allergy risk
(HR = 1.4, 95% CI 1.2 – 1.7, p < 0.001). Neither the crude
(hazard ratio 1.2, 95% CI 1.0 – 1.5, p = 0.10) nor adjusted
hazard ratio (HR = 0.9, 95% CI 0.7 – 1.3, p = 0.75) sug-
gested an effect of food allergies on major depression inci-
dence.
Discussion
In this analysis, an elevated incidence of non-food aller-
gies was found in respondents with major depression. An
effect of smoking on depression incidence was seen, and
smoking was found to protect against the incidence of
non-food allergies, as reported by Hjern et al. [33]. These
authors postulated that a suppressant effect of smoking
on immune function, or physical barriers in the lungs
caused by smoking-induced mucosal oedema could
explain this apparent protective effect [33]. Childhood
stressors were also associated with allergy incidence. No
effect of depression on the development of food allergies,
or effect of food allergies on depression incidence was
observed.
Whereas cross-sectional studies cannot distinguish an
effect of major depression on allergy risk from an effect of
allergies on major depression risk, the longitudinal design
employed here provided an opportunity to do so. Evi-
dence of an effect of major depression on allergy risk was
found, but the evidence for an effect in the opposite direc-
tion could not be confirmed after adjustment for potential
confounding variables. As such, the results of this study
primarily provide support for the idea that major depres-
sion is associated with an increased risk of allergies. This
could occur either because depression increases the risk of
allergies (perhaps because of immune system changes that
occur in depression, see discussion above) or because
some other risk factor is a determinant both of major
depression and allergies. Existing literature suggests that
genetic predisposition may be a determinant of both con-
ditions. Whereas genetic predisposition could not be
assessed in this study, another candidate as a shared risk
Table 2: Proportional hazard model for non-food allergy incidence, by major depression status
Variable Coefficient Hazard Ratio Z Statistic P-value 95% CI
Major Depression 0.22 1.2 1.99 0.046 1.0 - 1.5
Female 0.41 1.5 6.71 <.001 1.3 - 1.7
Age 12–18 0.41 1.5 1.71 0.087 0.9 - 2.4
Age 19–25 0.59 1.8 5.53 <.001 1.5 - 2.2
Age 26–45 0.41 1.5 4.68 <.001 1.3 - 1.8
Age 46–65* 0.31 1.4 3.38 0.001 1.1 - 1.6
Smoking -0.17 0.8 -2.40 0.017 0.7 - 1.0
Childhood Stressors 0.22 1.2 4.00 <.001 1.1 - 1.4
Intercept -2.48 - - - - -
* age > 65 in 1994 is the baseline category
Table 3: Two-year incidence of major depression in the NPHS* 
1994 to 1996, stratified by potential predictor variables
Depression Incidence %
(95% CI)
Non-food allergies 4.2 (3.1 – 5.3)
No non-food allergies 3.4 (2.9 – 3.9)
Male 2.6 (1.9–3.3)
Female 4.4 (3.8–5.0)
Age 12–18** 5.7 (3.8–7.6)
Age 19–25 3.4 (2.3–4.5)
Age 26–45 4.0 (3.2–4.8)
Age 46–65 2.6 (1.9–3.3)
Age 66+ 1.6 (0.9–2.4)
Daily smokers 5.9 (4.6–7.1)
Never/former/occasional smoker 2.6 (2.2–3.1)
Childhood or adult stressors reported 4.6 (3.8–5.4)
No childhood or adult stressors reported 2.0 (1.6–2.5)
* National Population Health Survey
** age at the baseline interview in 1994BioPsychoSocial Medicine 2009, 3:3 http://www.bpsmedicine.com/content/3/1/3
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factor, childhood stressors, was measured and the associ-
ation of major depression with allergy risk persisted after
adjustment for this variable. Childhood stressors could
trigger epigenetic mechanisms leading to long-term acti-
vation of the stress response [13]. In turn, in view of phys-
iological relationships between stress and immune
responses [12], epigenetic changes could be a shared
determinant of depression and allergies. Although the
association between major depression and allergy per-
sisted after adjustment for childhood stressors, direct
measures of stress and immune responses were not made,
so the results cannot support or refute this possibility.
Notably, the results of the study fail to support the
hypothesis that a psychosocial impact of allergies
increases the risk of major depression.
While this study provides the first longitudinal analysis of
a population sample, the study design was not capable of
precisely timing the onset of depressive episodes nor of
new onset allergies, therefore, temporal relationships
were not necessarily definitively disentangled. In addi-
tion, the major depression measure in the NPHS, the
CIDI-SF is a brief instrument that may not be as accurate
as more detailed research diagnostic instruments [37,38].
Misclassification bias resulting from diagnostic inaccuracy
may have caused a dilution in the observed strength of
association, and this may have contributed to the lack of
any apparent association between food allergies and
major depression. The validity of the self-reported aller-
gies is also questionable, but reproduction of a previously
reported protective effect of smoking provides some evi-
dence of methodological integrity. Since no direct assess-
ment of allergy status was carried out, it is possible that
health care seeking due to depression increased the prob-
ability of receiving a diagnosis of non-food allergies,
rather than of developing allergies per se.
Conclusion
These results indicate that people with major depression
are at increased risk of developing non-food allergies. This
may be due to an effect of major depression or to one or
more shared risk factors.
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